Fish Oil Might Help High-Risk Older Adults Avoid Alzheimer's
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
FRIDAY, Aug. 2, 2024 -- Fish oil supplements might help high-risk seniors stave off Alzheimer’s disease, a new study finds.
Older people with a higher genetic risk of Alzheimer’s experienced slower breakdown of their brain’s nerve cells if they took fish oil capsules, researchers reported Aug. 1 in the journal JAMA Network Open.
These people carry the APOE4 gene variant, which increases risk of Alzheimer’s and is associated with an earlier age of onset, according to the National Institute on Aging.
“The fact that neuronal integrity breakdown was slowed in people randomized to omega-3 treatment who are also at high risk for Alzheimer’s disease is remarkable, and warrants a larger clinical trial in more diverse populations in the future,” said researcher Gene Bowman, a neurology instructor with the McCance Center for Brain Health at Massachusetts General Hospital in Boston.
However, fish oil supplements did not benefit all seniors in general, researchers noted.
“Our findings showed that over three years, there was not a statistically significant difference between placebo and the group that took fish oil,” said researcher Dr. Lynne Shinto, a professor of neurology with the Oregon Health & Science University School of Medicine. “I don’t think it would be harmful, but I wouldn’t say you need to take fish oil to prevent dementia.”
For the study, researchers recruited 102 people ages 75 and older who had relatively low levels of omega-3 fatty acids, the beneficial ingredient in fish oil.
Fish oil supplements are touted as a means of improving brain function in people with memory problems, researchers said in background notes.
Participants received MRI brain scans at the start of the study and after three years looking for white matter lesions in the brain.
All had relatively high levels of white matter lesions but were otherwise healthy, with no dementia. These lesions can inhibit the ability of blood vessels to feed brain cells, increasing a person’s future risk of dementia, researchers said.
Half the participants were asked to take daily fish oil supplements, and the other half took a soybean-based placebo.
The MRI scans found a slight reduction in the progression of white matter lesions among people who took fish oil, but not enough to be statistically significant, researchers said.
However, APOE4 carriers who took fish oil experienced a dramatic reduction in the breakdown of their brain cell integrity as soon as one year after starting on fish oil, compared to the placebo group.
“This is the first dementia prevention trial to use modern prevention tools, such as a blood test and brain scan, to identify not only people at high risk for dementia, but also those well-suited to receive a specific nutritional intervention,” Bowman said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-02 23:15
Read more
- AHA: AI Analysis of Images, Videos Can ID Early Hypertension, Diabetes
- U.S. Overweight, Obesity Rates Set to Continue Increasing to 2050
- Why Treatments Can Fail Folks With 'Wet' Macular Degeneration -- and What Might Really Work
- Total Hip Replacement Revision Rates Vary With Type of Material Used
- Virtual Yoga Classes Aid Chronic Low Back Pain
- AbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions